Aug 01, 2024
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
Read more
Jul 25, 2024
Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update
Read more
Jul 24, 2024
Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium
Read more
Jul 17, 2024
Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program
Read more
Jun 13, 2024
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Read more
Jun 12, 2024
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Read more
Displaying 1 - 10 of 37